product summary
Loading...
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
Granzyme B Antibody (CLB-GB11) - BSA Free
catalog :
NBP1-50071
quantity :
0.1 mg
price :
409 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
CLB-GB11
reactivity :
human
application :
flow cytometry
more info or order :
citations: 7
Reference
An Z, Hsu M, Gicobi J, Xu T, Harrington S, Zhang H, et al. A Novel PD-L1 Antibody Promotes Antitumor Function of Peripheral Cytotoxic Lymphocytes after Radical Nephrectomy in Patients with Renal Cell Carcinoma. J Immunol. 2023;: pubmed publisher
Lucien F, Kim Y, Qian J, Orme J, Zhang H, Arafa A, et al. Tumor-Derived Extracellular Vesicles Predict Clinical Outcomes in Oligometastatic Prostate Cancer and Suppress Antitumor Immunity. Int J Radiat Oncol Biol Phys. 2022;114:725-737 pubmed publisher
Davidson T, Zhang H, Dong H, Grams M, Park S, Yan Y. Overcoming Immunotherapy Resistance With Radiation Therapy and Dual Immune Checkpoint Blockade. Adv Radiat Oncol. 2022;7:100931 pubmed publisher
Vera Aguilera J, Paludo J, McWilliams R, Zhang H, Li Y, Kumar A, et al. Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients. Melanoma Res. 2020;30:364-375 pubmed publisher
Zhang Q, He Y, Luo N, Patel S, Han Y, Gao R, et al. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma. Cell. 2019;179:829-845.e20 pubmed publisher
Bengsch B, Ohtani T, Khan O, Setty M, Manne S, O Brien S, et al. Epigenomic-Guided Mass Cytometry Profiling Reveals Disease-Specific Features of Exhausted CD8 T Cells. Immunity. 2018;48:1029-1045.e5 pubmed publisher
Yan Y, Cao S, Liu X, Harrington S, Bindeman W, Adjei A, et al. CX3CR1 identifies PD-1 therapy-responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy. JCI Insight. 2018;3: pubmed publisher
product information
master code :
NBP1-50071
SKU :
NBP1-50071
product name :
Granzyme B Antibody (CLB-GB11) - BSA Free
unit size :
0.1 mg
description :
The Granzyme B Antibody (CLB-GB11) - BSA Free from Novus is a mouse monoclonal antibody to Granzyme B. This antibody reacts with human,primate. The Granzyme B Antibody (CLB-GB11) - BSA Free has been validated for the following applications: Flow Cytometry,CyTOF-ready,Flow (Intracellular).
target :
Granzyme B
category :
Primary Antibodies
buffer :
TBS (pH 8.0)
clonality :
Monoclonal
clone :
CLB-GB11
concentration :
1 mg/ml
conjugate :
Unconjugated
host :
Mouse
immunogen :
Human NK cell line YT-INDY-derived granzyme B
isotype :
IgG1
purity :
Protein A purified
species :
Human,Primate
specificity :
The mouse monoclonal antibody CLB-GB11 recognizes granzyme B, a 31 kDa serine protease expressed in activated Tc cells and NK cells
theoretical molecular weight :
31 kDa
gene symbol :
GZMB
applications :
Flow Cytometry,CyTOF-ready,Flow (Intracellular)
USD :
409 USD
alt names :
C11, CCPI, CGL1, CGL-1, CSPB, CSP-B, CTLA1, CTSGL1, granzyme B, GranzymeB, GZMB, HLP, SECT
storage :
Store at 4C. Do not freeze.
more info or order :
company information
Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
novus@novusbio.com
https://www.novusbio.com
3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.